A Safety and Tolerability Study of ILB® in Patients With Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT03705390 · TERMINATED
Trial details
- NCT number
- NCT03705390
- Sponsor
- University of Birmingham
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-29
- Primary completion
- 2021-07-28
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.